C60.8

Clinical Causes: Chronic infections or inflammation, such as those caused by poor hygiene or human papillomavirus (HPV) infection History of phimosis or enclosing foreskin which can lead to smegma accumulation and irritation Smoking, which increases the risk of many types of cancers including penile cancer Uncircumcised penis, especially if combined with other risk factors Poor personal hygiene that leads to accumulation of smegma or irritants Aging, as risk increases with age History of penile injuries or traumatic lesions History of other sexually transmitted infections or precancerous lesions

Key Symptoms: Persistent or recurrent penile sores or ulcers that do not heal A growth, lump, or mass on the penis that may be ulcerated or bleeding Changes in skin color or thickening of penile skin Bleeding from the penis or from a penile sore Discharge that is abnormal or persistent from the penis Pain or discomfort during urination or intercourse Swelling or enlarged lymph nodes in the groin area Unusual penile redness, inflammation, or skin changes

Diagnosis Path: The diagnosis of malignant neoplasm of overlapping sites of the penis typically involves a combination of clinical examination and diagnostic procedures. Initial assessment includes visual inspection and palpation of the penis and groin. Confirmatory diagnosis may involve: - Biopsy: Taking a tissue sample for histopathological analysis - Imaging tests such as ultrasound, MRI, or CT scans to determine the extent of geographical spread - Sentinel lymph node biopsy or imaging to evaluate lymph node involvement - Laboratory tests to detect tumor markers or associated infections Early diagnosis is crucial in managing the disease effectively and planning appropriate treatment strategies.

Treatment Protocols: Management of this form of penile cancer may involve a combination of therapies tailored to the disease stage and patient condition. Treatment options include: - Surgical removal: Partial or total penectomy depending on the extent of the tumor - Local excision or laser therapy for superficial lesions - Radiation therapy to target cancerous tissues - Chemotherapy for advanced or metastatic disease - Topical medications or immunotherapy in early or localized disease - Regular follow-up and monitoring for recurrence or progression A multidisciplinary approach involving urologists, oncologists, and other specialists is often necessary to optimize outcomes.